SEARCH

SEARCH BY CITATION

References

  • Biemelt, S., Sonnewald, U., Galmbacher, P., Willmitzer, L. and Müller, M. (2003) Production of human papillomavirus type 16 virus-like particles in transgenic plants. J. Virol., 77, 92119220.
  • Bright, R.A., Carter, D.M., Daniluk, S., Toapanta, F.R., Ahmad, A., Gavrilov, V., Massare, M., Pushko, P., Mytle, N., Rowe, T., Smith, G. and Ross, T.M. (2007) Influenza virus-like particles elicit broader immune response than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine, 25, 38713878.
  • Cardineau, G., Mason, H.S., Vaneck, J.M., Kirk, D.D. and Wamsley, A.M. (2004) Vectors and cells for preparing immunoprotective compositions derived from transgnic plants. International Patent application WO2004/0098533.
  • Chen, B.J., Leser, G.P., Morita, E. and Lamb, R.A. (2007) Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol., 81, 71117123.
  • Congressional Budget Office (2008) U.S. Policy Regarding Pandemic-Influenza Vaccines. URL http://www.cbo.gov/ftpdocs/95xx/doc9573/09-15-PandemicFlu.pdf [accessed on 27 August 2009].
  • D’Aoust, M.-A., Lavoie, P.-O., Couture, M.M.-J., Trépanier, S., Guay, J.-M., Dargis, M., Mongrand, S., Landry, N., Ward, B.J. and Vézina, L.-P. (2008) Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol. J., 6, 930940.
  • D’Aoust, M.-A., Couture, M., Ors, F., Trépanier, S., Lavoie, P.-O., Dargis, M. and Vézina, L.-P. (2009) Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin. International Patent application WO2009/076778.
  • Fernández-San Millán, A., Ortigosa, S.M., Hervás-Stubbs, S., Corral-Martínez, P., Seguí-Simarro, J.M., Gaétan, J., Coursaget, P. and Veramendi, J. (2008) Human Papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol. J., 6, 427441.
  • Giritch, A., Marillonnet, S., Engler, C., Van Eldik, G., Botterman, J., Klimyuk, V. and Gleba, Y. (2006) Rapid high-yield expression of full-size IgG antibodies in plants coinfected with non-competitive viral vectors. Proc. Nat. Acad. Sci. USA, 103, 1470114706.
  • Gómez-Puertas, P., Albo, C., Pérez-Pastrana, E., Vivo, A. and Portela, A. (2000) Influenza virus matrix protein is the major driving force in virus budding. J. Virol., 74, 1153811547.
  • Greco, R., Michel, M., Guetard, D., Cervantes-Gonzalez, M., Pelucchi, N., Wain-Hobson, S., Sala, F. and Sala, M. (2007) Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine, 25, 82288240.
  • Grgacic, E.V.L. and Anderson, D.A. (2006) Virus-like particles: passport to immune recognition. Methods, 40, 6065.
  • Huang, Z. and Mason, H.S. (2004) Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium-mediated transient expression system. Plant Biotechnol. J., 2, 241249.
  • Huang, Z., Elkin, G., Maloney, B.J., Beuhner, N., Arntzen, C.J., Thanavala, Y. and Mason, H.S. (2005) Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine, 23, 18511858.
  • Huang, Z., Santi, L., LePore, K., Kilbourne, J., Arntzen, C.J. and Mason, H.S. (2006) Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine, 24, 25062513.
  • Huang, Z., Chen, Q., Hjelm, B., Arntzen, C. and Mason, H. (2009) A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol. Bioeng., 103, 706714.
  • Kang, S.-M., Song, J.-M., Quan, F.-S. and Compans, R.W. (2009) Influenza vaccines based on virus-like particles. Virus Res., 143, 140146.
  • Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letelier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A. and Legocki, A.B. (1999) A plant-derived edible vaccine against hepatitis B virus. FASEB J., 13, 17961799.
  • Kendal, A.P., Pereira, M.S. and Skehel, J. (1982) Concepts and procedures for laboratory-based influenza surveillance. Centers for Disease Control and Prevention and Pan American Health Organization, Atlanta, GA, B17-B35.
  • Kilbourne, E.D. (2006) Influenza pandemics of the 20th century. Emerg. Infect. Dis. [serial on the Internet]. URL http://www.cdc.gov/ncidod/EID/vol12no01/05-1254.htm [Accessed on August 27, 2009].
  • Kong, Q., Richter, L., Yang, Y.F., Arntzen, C.J., Mason, H.S. and Thanavala, Y. (2001) Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Nat. Acad. Sci. USA, 98, 1153911544.
  • Lerouge, P., Cabanes-Macheteau, M., Rayon, C., Fischette-Lainé, A.-C., Gomord, V. and Faye, L. (1998) N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol., 38, 3148.
  • Lico, C., Mancini, C., Italiani, P., Betti, C., Boraschi, D., Benvenuto, E. and Baschieri, S. (2009) Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice. Vaccine, 27, 50695076.
  • Maclean, J., Koekemoer, M., Olivier, A.J., Stewart, D., Hitzeroth, I.I., Rademacher, T., Fischer, R., Williamson, A.-L. and Rybicki, E.P. (2007) Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J. Gen. Virol., 88, 14601469.
  • Marillonnet, S., Thoeringer, C., Kandzia, R., Klimyuk, V. and Gleba, Y. (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat. Biotechnol., 23, 718723.
  • Mason, H.S., Man-Kit Lam, D. and Arntzen, C.J. (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. USA, 89, 1174511749.
  • Mason, H.S., Ball, J.M., Shi, J.-J., Jiang, X., Estes, M.K. and Arntzen, C.J. (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl Acad. Sci. USA, 93, 53355340.
  • Mechtcheriakova, I.A., Eldarov, M.A., Nicholson, L., Shanks, M., Skryabin, K.G. and Lomonossoff, G.P. (2006) The use of viral vectors to produce hepatitis B virus core particles in plants. J. Virol. Meth., 131, 1015.
  • Medicago (2009) Medicago’s Avian flu pandemic vaccine achieves 100% protection in a lethal challenge study in ferrets. URL http://www.medicago.com/English/news/News-Releases/News-ReleaseDetails/2009/MedicagosAvianflupandemicvaccineachieves100protectioninalethalchallengestudyinferrets1120905/default.aspx [accessed on 27 August 2009].
  • Mena, I., Vivo, A., Pérez, E. and Portela, A. (1996) Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids. J. Virol., 70, 50165024.
  • Mett, V., Musiychuk, K., Bi, H., Farrance, C.E., Horsey, A., Ugulava, N., Shoji, Y., De La Rosa, P., Palmer, G.A., Rabindran, S., Streatfield, S.J., Boyers, A., Russel, M., Mann, A., Lambkin, R., Oxford, J.S., Schild, G.C. and Yusibov, V. (2008) A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respi. Viruses, 2, 3340.
  • Musiychuk, K., Stephenson, N., Bi, H., Farrance, C.E., Orozovic, G., Brodelius, M., Brodelius, P., Horsey, A., Ugulava, N., Shamloul, A.-M., Mett, V., Rabindran, S., Streatfield, S.J. and Yusibov, V. (2007) A launch vector for the production of vaccine antigens in plants. Influenza and Other Respi. Viruses, 1, 1925.
  • Nemchinov, L.G. and Natilla, A. (2007) Transient expression of the ectodomain of matrix 2 (M2e) of avian influenza A virus in plants. Prot. Expression and Purif., 56, 153159.
  • Pan American Health Organization (2009) Vaccines for pandemic influenza A(H1N1). URL http://www.paho.org/English/AD/FCH/IM/QA_InfluenzaAH1N1_12Jul09_e.pdf [accessed on 27 August 2009].
  • Rasochova, L., Radam, J.M., Phelps, J.P. and Dang, N. (2007) Recombinant flu vaccines. International Patent application WO2007/0011904.
  • Richter, L.J., Thanaval, Y., Arntzen, C.J. and Mason, H.S. (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol., 18, 11671171.
  • Sainsbury, F. and Lomonossoff, G.P. (2008) Extremely high-level and rapid transient protein production in plants without the use of viral replication. Plant Physiol., 148, 12121218.
  • Saint-Jore-Dupas, C., Faye, L. and Gomord, V. (2007) From planta to pharma with glycosylation in the toolbox. Trends Biotechnol., 25, 317323.
  • Santi, L., Batchelor, L., Huang, Z., Hjelm, B., Kilbourne, J., Arntzen, C., Chen, Q. and Mason, H.S. (2008) An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine, 26, 18461854.
  • Séveno, M., Bardor, M., Paccalet, T., Gomord, V., Lerouge, P. and Faye, L. (2004) Glycoprotein sialylation in plants? Nat. Biotechnol., 22, 13511352.
  • Shoji, Y., Chichester, J.A., Bi, H., Musiychuk, K., De La Rosa, P., Goldschmidt, L., Horsey, A., Ugulava, N., Palmer, G.A., Mett, V. and Yusibov, V. (2008) Plant-expressed HA as seasonal influenza vaccine candidate. Vaccine, 26, 29302934.
  • Shoji, Y., Bi, H., Musiychuk, K., Rhee, A., Horsey, A., Roy, G., Green, B., Shamloul, M., Farrance, C.E., Taggart, B., Mytle, N., Ugulava, N., Rabindran, S., Mett, V., Chichester, J.A. and Yusibov, V. (2009a) Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of influenza. Vaccine, 27, 10871092.
  • Shoji, Y., Farrance, C.E., Bi, H., Shamloul, M., Green, B., Manceva, S., Rhee, A., Ugulava, N., Roy, G., Musiychuk, K., Chichester, J.A., Mett, V. and Yusibov, V. (2009b) Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants. Vaccine, 27, 34673470.
  • Smith, M.L., Mason, H.S. and Shuler, M.L. (2002) Hepatitis B surface antigen (HBsAg) expression in plant cell culture: kinetics of antigen accumulation in batch culture and its intracellular form. Biotechnol. Bioeng., 80, 812822.
  • Smith, M.L., Richter, L., Arntzen, C.J., Shuler, M.L. and Mason, H.S. (2003) Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. Vaccine, 21, 40114021.
  • Spitsin, S., Andrianov, V., Pogrebnyak, N., Smirnov, Y., Borisjuk, N., Portocarrero, C., Veguilla, V., Koprowski, H. and Golovkin, M. (2009) Immunological assessment of plant-derived avian flu H5/HA1 variants. Vaccine 27, 12891292.
  • Tacket, C.O., Mason, H.S., Losonsky, G., Estes, M.K., Levine, M.M. and Arntzen, C.J. (2000) Human immune response to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis., 182, 302305.
  • Thanavala, Y., Yang, Y.F., Lyons, P., Mason, H.S. and Arntzen, C. (1995) Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Nat. Acad. Sci. USA, 92, 33583361.
  • Treanor, J.J., Schiff, G.M., Hayden, F.G., Brady, R.C., Hay, C.M., Meyer, A.L., Holden-Wiltse, J., Liang, H., Gilbert, A. and Cox, M. (2007) Safety and immunogenicity of a bacculovirus-expressed hemagglutinin influenza vaccine. A randomized controlled trial. J. Am. Med. Assoc., 297, 15771582.
  • Tsuda, S., Yoshika, K., Tanaka, T., Iwata, A., Yoshikawa, A., Watanabe, Y. and Okada, Y. (1998) Application of the human hepatitis B virus core antigen from transgenic tobacco for serological diagnosis. Vox Sang., 74, 148155.
  • Usha, R., Rohll, J.B., Spall, V.E., Shanks, M., Maule, A.J., Johnson, J.E. and Lomonossoff, G.P. (1993) Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology, 197, 366374.
  • Varsani, A., Williamson, A.-L., Rose, R.C., Jaffer, M. and Rybicki, E.P. (2003) Expression of human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Arch. Virol., 148, 17711786.
  • Vézina, L.P., Faye, L., Lerouge, P., D’Aoust, M.-A., Marquet-Blouin, E., Burel, C., Lavoie, P.-O., Bardor, M. and Gomord, V. (2009) Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol. J., 7, 442455
  • Warzecha, H., Mason, H.S., Lane, C., Tryggvesson, A., Rybicki, E., Williamson, A.L., Clements, J.D. and Rose, R.C. (2003) Oral immunogenicity of human papillomavirus-like particles expressed in potato. J. Virol., 77, 87028711.
  • World Health Organization (2002) WHO Manual on animal influenza diagnosis and surveillance. URL http://www.wpro.who.int/NR/rdonlyres/EFD2B9A7-2265-4AD0-BC98-97937B4FA83C/0/manualonanimalaidiagnosisandsurveillance.pdf [accessed on August 27].
  • World Health Organization (2009a) Changes in reporting requirements for pandemic (H1N1) 2009 virus infection. URL http://www.who.int/csr/disease/swineflu/notes/h1n1_surveillance_20090710/en/index.html [accessed on 27 August 2009].
  • World Health Organization (2009b) Pandemic influenza vaccine manufacturing process and timeline. URL http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090806/en/index.html [accessed on 27 August 2009].
  • World Health Organization (2009c) Transcript of WHO Virtual Press Conference of 6 August 2009 with Dr Marie-Paule Kieny, Director of the Initiative for Vaccine Research at WHO Headquarters and Gregory Hartl, Spokesperson for H1N1. URL http://www.who.int/mediacentre/pandemic_h1n1_presstranscript_2009_08_06.pdf [accessed on 27 August 2009].